Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyBeR-Lymph: R-BAC for R/R DLBCL
NCT02758925Phase 2Unknown
- Sponsor
- CHU Caen Normandie
- Start
- Jun 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cytarabine in diffuse large B-cell lymphoma (DLBCL), sponsored by CHU Caen Normandie. Status: unknown.
02
Drugs
cytarabine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02758925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02758925.